Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling

Podobne zapisy

• Update on third-generation EGFR tyrosine kinase inhibitors
  od: Gray, Jhanelle, i wsp.
  Wydane: (2014)
• Overcoming acquired resistance to AZD9291, a third generation EGFR inhibitor, through modulation of MEK/ERK-dependent Bim and Mcl-1 degradation
  od: Shi, Puyu, i wsp.
  Wydane: (2017)
• Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
  od: Westover, D, i wsp.
  Wydane: (2018)
• Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
  od: Xu, Haiyuan, i wsp.
  Wydane: (2019)
• Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
  od: Zang, Hongjing, i wsp.
  Wydane: (2020)